Mandate

Vinge acts as counsel to Orkla in connection with the acquisition of Health and Sports Nutrition Group

November 21, 2017 EU, Competition and Regulatory

Vinge acts as counsel to Orkla in connection with the acquisition of Health and Sports Nutrition Group HSNG AB (”HSNG”). The seller is Qliro Group AB (publ).

HSNG is a leading actor within e-commerce of health and sport nutrition in the Nordics and runs its business mainly through the internet stores Gymgrossisten.com and Bodystore.com. In addition, Gymgrossisten has physical franchise stores.

Orkla is a leading supplier of branded consumer goods and concept solutions to the grocery, out-of-home and bakery markets in the Nordics, Baltics and selected markets in Central Europe and India. Orkla is listed on the Oslo Stock Exchange and its head office is in Oslo. In 2016, the Group had a turnover of approximately NOK 38 billion, and 18,000 employees at year end.

The transaction is subject to the approval of the relevant competition authorities.

Vinge’s team consists, among others, of responsible partner Peter Sundgren as well as counsel Joacim Rydergård and associates Christina Odengran, Christoffer Nordin, Emelie Håkansson, Mika Jordan, Sara Strandberg, Filip Markhed and Ilze Lukins. Partner Johan Karlsson as well as, among others, associates Trine Osen Bergqvist and Xandra Ståhlberg are advising on competition law issues.

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025